- Joined
- Mar 31, 2007
- Messages
- 42,611
- Reaction score
- 24,194
I guess I should say, I'd stick to your gun at 220 as a taper point, with some more hope that it actually gets there. Given that I tend to value at a small fraction of total market cap unless you can justify it being a likely market leader.Why would I do that? $220 was my original exit and now they have a diabetes drug that shows promise and not even on market yet. Plus they print money with their Cystic Fibrosis drug and all generics on lockdown for their Cystic Fibrisos drug. It’s not a sexy 20% daily pop but I am trying not trying to sell anything else until 2022 anyway. I loaded up when it dropped below 180, it was a Ron Popeil set it and forget it buy for me below 180.